Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops
Pfizer’s twice-daily version of its experimental weight-loss pill now joins a long list of other eliminated obesity drugs. Pfizer’s move to scrap two obesity drug candidates last year shows how difficult it is to develop an effective, safe and tolerable weight loss treatment. Before successful weight-loss treatments like Wegovy and Ozempic, the path to treating … [Read more…]